JACKSON, MI - April 07, 2026 - PRESSADVANTAGE - Nu-Ice Blasting™, a U.S.-based, veteran-owned manufacturer of dry ice ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results